Lexicon Pharmaceuticals has completed the enrolment of subjects for the multicentre, Phase IIb PROGRESS trial of the new ...

The following is a summary of “Weaning of non COPD patients at high-risk of extubation failure assessed by lung ultrasound: ...

The following is a summary of “A mobile app to support self-management and remotely monitor disease impact in rheumatoid ...

THE VIBRANT city of Los Angeles, California welcomed over 12,000 clinicians, scientists, epidemiologists, researchers, ...

Integrating AI in gastrointestinal endoscopy enhances image analysis, reduces diagnostic variability, and improves patient ...

Nearly half (47%) of all clinical trials remain unpublished. Whether a trial is published and how long it takes is influenced by whether there are positive results, how large the trial is and if it is ...

Safe, effective one-year outcomes in severe tricuspid regurgitation, enhancing symptoms and reducing admissions.

Nearly 4 million patients with chronic obstructive pulmonary disease (COPD) or asthma die each year, mostly from severe acute exacerbations.1 For the past 60 years, systemic corticosteroids have been ...

2024 年 12 月 6 日 - 8 日，欧洲肿瘤内科学会亚洲年会（ESMO Asia）将在新加坡盛大召开。本届会议将汇聚全球专家学者，集中展示和讨论肿瘤学领域的最新科学和临床进展，为肿瘤领域带来一场学术盛宴。此次会议中，「Dato-DXd ...

Researchers evaluated the efficacy and safety of ixekizumab over a 16-week period for the treatment of juvenile psoriatic arthritis or enthesitis-related arthritis.

Compared with usual care, care via the PROVIDE model, a mode of telemedicine, may improve the mental health of patients with depression and anxiety disorders.